Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Scotiabank Upgrades Manulife Financial to Sector Outperform

Scotiabank Upgrades Manulife Financial to Sector Outperform

Scotiabank analyst Meny Grauman upgrades Manulife Financial (NYSE:MFC) from Sector Perform to Sector Outperform.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Scotiabank analyst Meny Grauman upgrades Manulife Financial (NYSE:MFC) from Sector Perform to Sector Outperform.

Price Over Earnings Overview: CVS Health

By Benzinga Insights

November 10, 2:45 PM

In the current market session, CVS Health Inc. (NYSE:CVS) price is at $66.95, after a 0.31% increase. However,…

CVS

News

Why Alteryx (AYX) Shares Are Popping Off Monday

By Henry Khederian

February 13, 11:08 AM

Alteryx Inc (NYSE: AYX) shares are trading higher by 6.11% to $66.71 Monday morning after Citigroup maintained a Buy rating on the stock and raised its price target from $75 to $80.

AYX

Morgan Stanley Maintains Overweight on Natera, Raises Price Target to $72

By Benzinga Newsdesk

March 2, 11:17 AM

Morgan Stanley analyst Tejas Savant maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $70 to $72.

NTRA

HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $24 Price Target

By Benzinga Newsdesk

March 1, 7:09 AM

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $24 price target.

TGTX

Scotiabank Upgrades Manulife Financial to Sector Outperform

Related Posts

Price Over Earnings Overview: CVS Health

Why Alteryx (AYX) Shares Are Popping Off Monday

Morgan Stanley Maintains Overweight on Natera, Raises Price Target to $72

HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $24 Price Target